Do Visa and Mastercard Need a Coronavirus Vaccine to Win in 2021?

Matthew Frankel, CFP, The Motley Fool
·3 min read

Visa (NYSE: V) and Mastercard (NYSE: MA) have held up better than most other financial sector stocks in 2020, and this certainly makes sense as the companies make money from consumer spending, regardless of whether sales come in-store or through e-commerce. In this Nov. 25 Fool Live video clip, Fool.com contributors Matt Frankel, CFP, and Brian Feroldi take a look at whether Visa and Mastercard are so-called "reopening" stocks, or if they don't need a vaccine to thrive. Matthew Frankel: Looking at a couple of questions, Laura's comment says, "What about MasterCard, Visa, etc?" That's a very good question because, well Brian has given me a big thumps up right now, they're excellent companies.